2014
DOI: 10.1136/bmj.g6241
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis and management of gallstone disease: summary of NICE guidance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
31
0
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 61 publications
(36 citation statements)
references
References 1 publication
0
31
0
3
Order By: Relevance
“…Although there are several guidelines available to surgeons and physicians on the clinical benefits of ELC, only one 14 has incorporated health economic evidence, based solely on cost-utility analysis. Its limitations were acknowledged in Appendix J of those same guidelines 14 . These included a limited time horizon, assumptions made in the data sources used, and a delay between ELC and DLC longer than that found in most clinical papers (up to 3 times longer).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although there are several guidelines available to surgeons and physicians on the clinical benefits of ELC, only one 14 has incorporated health economic evidence, based solely on cost-utility analysis. Its limitations were acknowledged in Appendix J of those same guidelines 14 . These included a limited time horizon, assumptions made in the data sources used, and a delay between ELC and DLC longer than that found in most clinical papers (up to 3 times longer).…”
Section: Discussionmentioning
confidence: 99%
“…The definition and recommended management of ACC are available in evidence-based guidelines 14,15 . These guidelines include significant support for the role of ELC in managing ACC.…”
Section: Introductionmentioning
confidence: 99%
“…Gallstone disease is common and aff ects 10-15% of adults in Western populations [12]. The vast majority of patients remain asymptomatic.…”
Section: Discussionmentioning
confidence: 99%
“…Folgende Leitlinien und Studien waren für die Planung von besonderer Relevanz ▪ DGVS-Leitlinien 2000 und 2007 [12,13] ▪ TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis [14] ▪ NICE Clinical Guideline 188 2014 [15] ▪ Neederlandse richtlijn Galsteenlijden 2016 [16] ▪ EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones 2016 [17] ▪ British guidelines on the management of common bile duct stones 2017 [18] Als weitere relevante Quelle wurde die IQWIG Gesundheitsinformation Gallensteine 2012 berücksichtigt (http://www.iqwig.de/).…”
Section: üBerarbeitungsstrategie Und Priorisierung Der Empfehlungenunclassified